Business · 18/03/2026Updated: 10/16/2026 · 1 min read
FDA Proposes Requirement for Premarket Approval of Blood Irradiators to Prevent Metastasis
Summary
The FDA is proposing to require premarket approval applications for blood irradiators intended to prevent metastasis in cancer patients, a move aimed at reducing the risk of illness or injury.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →